Research programme: antibacterials - Medarex/Ferric Technologies
Alternative Names: Antibacterials research programme - Medarex/Ferric TechnologiesLatest Information Update: 03 May 2007
At a glance
- Originator Ferric Technologies; Medarex
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 03 May 2007 No development reported - Preclinical for Bacterial infections in USA (unspecified route)
- 29 Jun 2005 This programme is still in active development
- 11 Mar 2003 Preclinical trials in Bacterial infections in USA (unspecified route)